Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariarosaria Conte

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Cell Death & Disease|April 2, 2025
Unravelling the impact of the chromobox proteins in human cancersShabana Noreen, Nicla Simonelli, Rosaria Benedetti, et al.
Molecules (Basel, Switzerland)|July 12, 2020
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer CellsRossella Fioravanti, Stefano Tomassi, Elisabetta Di Bello, et al.
Chemmedchem|November 21, 2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer ActivityClemens Zwergel, Elisabetta Di Bello, Rossella Fioravanti, et al.
Chemmedchem|April 27, 2007
Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitorsAntonello Mai, Sergio Valente, Donghang Cheng, et al.
Cardiovascular Diabetology|July 24, 2021
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicinVincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, et al.
EMBO Reports|June 6, 2009
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
Marine Drugs|November 6, 2019
Monoacylglycerides from the Diatom <i>Skeletonema marinoi</i> Induce Selective Cell Death in Cancer CellsMarco Miceli, Adele Cutignano, Mariarosaria Conte, et al.
EMBO Reports|January 13, 2021
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.
Chemmedchem|February 8, 2014
Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cellsAlessia Lenoci, Stefano Tomassi, Mariarosaria Conte, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Cell Death & Disease|April 2, 2025
Unravelling the impact of the chromobox proteins in human cancersShabana Noreen, Nicla Simonelli, Rosaria Benedetti, et al.
Molecules (Basel, Switzerland)|July 12, 2020
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer CellsRossella Fioravanti, Stefano Tomassi, Elisabetta Di Bello, et al.
Chemmedchem|November 21, 2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer ActivityClemens Zwergel, Elisabetta Di Bello, Rossella Fioravanti, et al.
Chemmedchem|April 27, 2007
Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitorsAntonello Mai, Sergio Valente, Donghang Cheng, et al.
Cardiovascular Diabetology|July 24, 2021
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicinVincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, et al.
EMBO Reports|June 6, 2009
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
Marine Drugs|November 6, 2019
Monoacylglycerides from the Diatom <i>Skeletonema marinoi</i> Induce Selective Cell Death in Cancer CellsMarco Miceli, Adele Cutignano, Mariarosaria Conte, et al.
EMBO Reports|January 13, 2021
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.
Chemmedchem|February 8, 2014
Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cellsAlessia Lenoci, Stefano Tomassi, Mariarosaria Conte, et al.
Pageof 7